The project, which is an initiative of the Quest Diagnostics Foundation, aims to expand healthcare access in the area, including through no-cost laboratory testing.

The guidelines address items like interpretation of results that may be affected by gender-affirming hormone therapy and improving electronic health record practices.

The PCR-based panels detect up to 22 of the most common bacteria, viruses, and parasites associated with gastroenteritis.

The company aims to complete the international development and validation of the test, as well as to obtain European regulatory approval and commercialize it as a service and a kit.

Last week, readers were most interested in a story about Achieve Diagnostics buying the pharmacogenomic assets of H&M Molecular Diagnostics.

The company will conduct a prospective, multicenter study enrolling approximately 954 men with elevated PSA levels who are scheduled for a prostate biopsy.

The firm currently offers its HerResolve multiomic test for endometriosis that looks at seven biomarkers, including microRNAs ...

The Germany-based company is developing a handheld infectious disease testing platform that does not require electricity.

The planned trial will investigate Eledon's tegoprubart, a therapy designed to prevent organ rejection in kidney transplantation.

Verici Dx said on Wednesday that its Tutivia lab-developed test for acute kidney transplant rejection risk has been approved by the New York State Department of Health (NYSDOH). With the approval ...

NEW YORK – Alzheimer's diagnostic company Alzpath announced on Wednesday that it has signed a global licensing agreement with Abbott to develop blood-based tests for Alzheimer's disease. Financial and ...